Heidelberg Pharma AG (HPHA) — Strategic Asset Allocation Index
Heidelberg Pharma AG (HPHA) has a Strategic Asset Allocation Index of 7.8% as of August 2023. Strategic assets (PP&E of €4.01 Million plus long-term investments of €-) total €4.01 Million, measured against net assets of €51.49 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Heidelberg Pharma AG Strategic Asset Allocation Index (2016–2021)
This chart shows how Heidelberg Pharma AG's Strategic Asset Allocation Index has evolved across 6 annual periods from 2016 to 2021. As of August 2023, the index stands at 7.8%, representing strategic assets of €4.01 Million against net assets of €51.49 Million EUR. Explore how efficiently does Heidelberg Pharma AG generate cash to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Heidelberg Pharma AG (2016–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Heidelberg Pharma AG from 2016 to 2021, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Heidelberg Pharma AG (HPHA) market capitalisation.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 54.8% | €3.67 Million | €3.67 Million | €- | €6.70 Million | ▲ +30.7 pp |
| 2020 | 24.2% | €3.11 Million | €3.11 Million | €- | €12.88 Million | ▲ +9.3 pp |
| 2019 | 14.9% | €2.43 Million | €2.43 Million | €- | €16.29 Million | ▲ +7.4 pp |
| 2018 | 7.5% | €1.95 Million | €1.95 Million | €- | €25.89 Million | ▲ +4.0 pp |
| 2017 | 3.5% | €1.30 Million | €1.30 Million | €- | €37.02 Million | ▼ -9.5 pp |
| 2016 | 13.0% | €1.27 Million | €1.27 Million | €- | €9.76 Million | — |